NSTR Northstar Neuroscience Inc.

OTO
$3.45

Northstar Neuroscience Inc. (NSTR) is confirmed to report earnings on November 12, 2026, after the market close.

Earnings Date
Nov 12
Thursday · 4:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Northstar Neuroscience Inc.

NORTHSTAR NEUROSCIENCE INC., is a medical device company committed to providing neurostimulation therapies for people who suffer from stroke and other neurological disorders. Their mission is to improve function and quality of life for patients. The company's innovative technology is designed to deliver targeted electrical stimulation to the outermost layer of the brain, called the cortex, in a process referred to as cortical stimulation. Northstar's proprietary Renova Cortical Stimulation System is an investigational device that delivers targeted electrical stimulation to the outer surface of the brain - the cerebral cortex. The Renova system is currently under investigation for several indications.

Charts powered in part by Lightweight Charts™ by TradingView.